Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
about
Role of erythropoietin in cancer-related anaemia: a double-edged sword?The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.
P2860
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@ast
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@en
type
label
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@ast
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@en
prefLabel
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@ast
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@en
P1476
Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
@en
P2093
George D Demetri
Jayesh Desai
P304
P356
10.1016/J.BEHA.2005.01.018
P577
2005-01-01T00:00:00Z